Show simple item record

dc.contributor.authorShringarpure, K S
dc.contributor.authorIsaakidis, P
dc.contributor.authorSagili, K D
dc.contributor.authorBaxi, R K
dc.date.accessioned2015-07-21T22:43:19Z
dc.date.available2015-07-21T22:43:19Z
dc.date.issued2015-07-13
dc.identifier.citationLoss-To-Follow-Up on Multidrug Resistant Tuberculosis Treatment in Gujarat, India: The WHEN and WHO of It. 2015, 10 (7):e0132543 PLoS ONEen_GB
dc.identifier.issn1932-6203
dc.identifier.pmid26167891
dc.identifier.doi10.1371/journal.pone.0132543
dc.identifier.urihttp://hdl.handle.net/10144/560842
dc.description.abstractMultidrug-resistant Tuberculosis (MDR-TB) is a rising global threat to public health and concerted efforts for its treatment are diluted if the outcomes are not successful, loss to follow up (LFU) being one of them. It is therefore necessary to know the proportion and the associated reasons for LFU and devise effective patient-centered strategies to improve retention in care.
dc.language.isoenen
dc.publisherPublic Library of Scienceen_GB
dc.rightsPublished by Public Library of Science, [url]http://www.plosone.org/[/url] Archived on this site by Open Access permissionen_GB
dc.titleLoss-To-Follow-Up on Multidrug Resistant Tuberculosis Treatment in Gujarat, India: The WHEN and WHO of Iten
dc.identifier.journalPloS Oneen_GB
refterms.dateFOA2019-03-04T12:27:32Z
html.description.abstractMultidrug-resistant Tuberculosis (MDR-TB) is a rising global threat to public health and concerted efforts for its treatment are diluted if the outcomes are not successful, loss to follow up (LFU) being one of them. It is therefore necessary to know the proportion and the associated reasons for LFU and devise effective patient-centered strategies to improve retention in care.


Files in this item

Thumbnail
Name:
Shringarpure KS et al - 2015 - ...
Size:
361.4Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record